Cette combinaison n'existe pas.


A 360° study to inform your strategy:

  • #1 – Learn how pharma and medtech wrap services around their products to deliver more value
  • #2 – Uncover how leaders harness digital to enable value-adding services
  • #3 – Identify barriers to overcome and key success factors
  • #4 – Clarify the capabilities you need to effectively engage payers, providers, patients, and to co-develop and disseminate integrated solutions that meet their needs.

Renewed pressure to deliver greater value for money:

The cost of healthcare continues to rise despite decades of pressure to contain spending. The underlying factors remain – rising incomes, ageing populations, increasing prevalence and complexity of disease, poor productivity, plus innovative but costly medical technology.

The rising cost of healthcare is unsustainable. Pressure is mounting on everyone in the health ecosystem to deliver better health outcomes, improved experiences for patients and care teams, and containing costs.

Beyond-the-pill digital offerings are becoming essential:

With a focus on outcomes, patient access to health technologies is increasingly determined by real-world clinical and economic value.

The era of patient-centric digital technologies that link services to medicines and medical devices has dawned. They hold the promise of better clinical outcomes, improved patients’ lives and reduced healthcare costs.

Payers are dipping a toe in the water. Pharma and medtech are starting to see such services as essential for market access as well as real-world data capture, innovative contracting and faster dissemination of innovation.

Capturing a golden opportunity:

Advances in digital technology offer pharma and medtech the opportunity to expand their role in the healthcare value chain, strengthen their bond with health consumers, and deliver better outcomes for patients and other stakeholders.

Nevertheless, designing and deploying at-scale holistic offerings needs more than just technology. The lessons from first-gen initiatives are clear.

Success requires:

  1. Clearly stated intent
  2. Visible top management commitment
  3. Internalization of patient-centricity
  4. Outcomes focus in the culture of the organization
  5. A transformation towards outcomes focused collaboration and solution co-creation.

In this report, we share insights on innovative initiatives, leading players and the capabilities we consider critical to scale-up holistic solutions and thrive in an outcomes-driven environment.

Methodology

The information for this report was gathered from multiple sources, including:

  • Semi-structured interviews (Face-to-face or telephone) with 70 leaders working in different regions of the world either for the pharma and medtech industry or for other stakeholders in health systems (Patient groups, providers, policy makers, payers)
  • Unstructured interviews with 8 leaders working for digital therapeutics or digital health companies
  • Secondary research from publically available sources of information.

About StarGen

Hervé DREVOT is a partner at StarGen.

StarGen helps pharma and medtech companies define their innovation strategy and expand their offerings beyond the pill.  StarGen facilitates joint working (Patients, Providers, Payers, and Industry), co-creation and implementation of patient-centric solutions to improve outcomes.





Contact

 Une question?

 Nous sommes là pour vous aider!

JE REMPLIS LE FORMULAIRE POUR ETRE CONTACTE PAR UN CONSEILLER                     


     
             




NOTRE CONSULTANT
Hélène CHARRONDIERE

FICHE TECHNIQUE

TARIF
A partir de 3350 € H.T


Rédigée en français
Décembre 2019
182 pages


 

NEWSLETTER


Partager sur les réseaux sociaux






1- EXECUTIVE SUMMARY

  1. WHY AND HOW TO ADD VALUE BEYOND THE PRODUCT
  2. BEYOND-THE-PILL SOLUTIONS ARE TAKING OFF
  3. KEYS TO OVERCOME CHALLENGES AND MAXIMIZE SUCCESS

2- HEALTHCARE UNDER PRESSURE

  1. POPULATIONS ARE AGEING
  2. AGEING POPULATIONS ARE NOT NECESSARILY HEALTHIER
  3. HIGHER LEVELS OF CHRONIC DISEASE
  4. HEALTH NEEDS ARE BECOMING MORE COMPLEX
  5. DEMAND FOR HEALTH SERVICES IS RISING – AND SO ARE COSTS
  6. HEALTHCARE RESOURCES ARE NOT USED EFFICIENTLY
  7. PATIENTS WAITING LONGER FOR INNOVATIVE THERAPIES

3- STRATEGIC OPPORTUNITIES FOR INDUSTRY TO MEET STAKEHOLDERS’ NEEDS

  1. DELIVERING ON THE NEEDS OF STAKEHOLDERS
  2. OPPORTUNITIES FOR PHARMA AND MEDTECH TO CO-CREATE MEANINGFUL VALUE
  • BOOST THE ENGAGEMENT OF INDIVIDUALS IN THEIR HEALTH AND WELLBEING
  • USE MEDICINES AND OTHER HEALTH TECHNOLOGIES TO THEIR FULLEST POTENTIAL
  • REDUCE UNWARRANTED VARIATIONS IN CARE
  • ENABLE REMOTE PATIENT MONITORING
  • ENABLE CLOSED-LOOP PRECISION MEDICINE
  • SUPPORT THE SHIFT TO PATIENT-CENTRIC INTEGRATED CARE AND THE MIGRATION OF CARE AWAY FROM HOSPITALS
  • SUPPORT VALUE-BASED CONTRACTING WITH DATA AND MEASUREMENT OF VALUE

4- INNOVATIVE INITIATIVES IN KEY DISEASE AREAS

  1. CANCER
  2. COPD
  3. DIABETES
  4. INFLAMMATORY DISEASES
  5. OBESITY
  6. MULTIPLE SCLEROSIS
  7. RARE DISEASES

5- PROFILES OF LEADING PLAYERS

ADHERIUM, AKILI, ALIVECOR, APPLE HEALTH, ASTRAZENECA, BIGHEALTH/SLEEPIO, CARDIOLOGS, CLICK THERAPEUTICS, DASSAULT SYSTEMS, DEXCOM, DIABELOOP, GAIA, GLOOKO, IBM HEALTH, JOHNSON & JOHNSON, LIVONGO, MEDTRONIC, MICROSOFT, MOOVCARE, MY MHEALTH, NOVARTIS, OBSERVIA, OMADA, PEAR THERAPEUTICS, PHILIPS HEALTHCARE, PROPELLER, PROTEUS, ROCHE, S3 CONNECTED HEALTH, VARIAN/NOONA, VOLUNTIS ET WELLDOC

6- 360° PERSPECTIVES OF STAKEHOLDERS ON PATIENT-CENTRIC SOLUTIONS

  1. METHODOLOGY
  2. PROFILE OF RESPONDENTS –POLICY MAKERS, PAYERS, PATIENT GROUPS, PROVIDERS, PHARMA, MEDTECH
  3. KEY TAKEAWAYS
  4. STAKEHOLDERS’ EVALUATION OF FIRST GENERATION “BEYOND-THE-PILL”  SOLUTIONS
  5. WHAT STAKEHOLDERS EXPECT OF “BEYOND-THE-PILL”  SOLUTIONS
  6. WHERE STAKEHOLDERS SEE MORE PROMISING OPPORTUNITIES

7- THE KEY DETERMINANTS OF SUCCESS

  1. GROUND INITIATIVES IN A VALUE CREATION STRATEGY
  2. FORM GENUINE PARTNERSHIPS TO CO-DEVELOP AND SCALE UP JOINT SOLUTIONS
  3. EMBED DATA GENERATION AND VALUE MEASUREMENT TO ENABLE CONTINUOUS IMPROVEMENT
  4. EARLY CLARIFY THE STRATEGY TO ACCELERATE ADOPTION AND IMPLEMENTATION IN ROUTINE WORKFLOW
  5. ANTICIPATE OPERATIONALIZATION AND ENHANCE THE CAPABILITIES REQUIRED
  6. FOSTER PATIENT/CUSTOMER CENTRICITY AND OUTCOMES FOCUS




Contact

 Une question?

 Nous sommes là pour vous aider!

JE REMPLIS LE FORMULAIRE POUR ETRE CONTACTE PAR UN CONSEILLER                     


     
             




NOTRE CONSULTANT
Hélène CHARRONDIERE

FICHE TECHNIQUE

TARIF
A partir de 3350 € H.T


Rédigée en français
Décembre 2019
182 pages


 

NEWSLETTER


Partager sur les réseaux sociaux






StarGen accompagne les industriels du médicament, du diagnostic et du dispositif médical dans la définition de leur stratégie d’innovation et la formalisation de leur proposition de valeur. Le cabinet travaille notamment sur l’identification d’opportunités d’amélioration du parcours patient et la co-création de solutions Beyond-the-pill.





Contact

 Une question?

 Nous sommes là pour vous aider!

JE REMPLIS LE FORMULAIRE POUR ETRE CONTACTE PAR UN CONSEILLER                     


     
             




NOTRE CONSULTANT
Hélène CHARRONDIERE

FICHE TECHNIQUE

TARIF
A partir de 3350 € H.T


Rédigée en français
Décembre 2019
182 pages


 

NEWSLETTER


Partager sur les réseaux sociaux






Articles vus récemment